Competing through Customer Value: 5 steps towards an exciting era for life science

‘Customer Value’ is known to be the new competitive battleground for life science companies

Unsustainable growth in healthcare costs are increasing the discomfort felt in the symbiotic relationship between life science companies and healthcare systems, perhaps to intolerable levels, diluting the focus on delivering value to patients.

Slow-moving but inevitable healthcare reform will eventually trigger structural reform to life science – the companies recognized as leaders today may not be the leaders of tomorrow. Rather than wait for procurement-led value to arrive, there are opportunities to act now in ways that better align the creation of value for all stakeholders and simultaneously improve their competitive position for when it does.

The are several no-regret decisions that can be made immediately to explore and define the next generation of life science companies that deliver more value. The people who act now will be the ones who are most likely to lead the industry into an exciting new era.

Driven by this ‘core insight’ and with years of experience as experts in customer experience, digital health, and organizational transformation, we have crafted our views into this white paper, with expert advice from others in the field. It explores both challenges and opportunities that will help usher in a new era for life science companies.

Other key topics explored in the white paper:

• Does customer value always align to business value?
• Can we invest and develop in shared value?
• Are our evolving commercial models fit for purpose?
• How can effective use of technology help improve value?
• Are our management capabilities designed to deliver value?